Here are what the editors at HealthDay consider to be the most important developments in HIV & AIDS for November 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
FDA to Update Medical Device Approvals Process
TUESDAY, Nov. 27, 2018 (HealthDay News) — A major update of the United States’ system for approving medical devices was announced yesterday by the Food and Drug Administration.
CBS/AP News Article
More Information
Four Principles Underlie Patient and Family Partnership in Care
TUESDAY, Nov. 27, 2018 (HealthDay News) — Patient and family partnership in care should include treatment of patients and families with dignity and respect, their active engagement in all aspects of care, and their contribution to the improvement of health care systems and education of health care professionals, according to a position paper published online Nov. 27 in the Annals of Internal Medicine.
Position Paper
Editorial (subscription or payment may be required)
ACA Coverage Substantial, but Did Not Impact Labor Markets
MONDAY, Nov. 26, 2018 (HealthDay News) — Millions of workers gained insurance coverage under the Affordable Care Act (ACA) without adverse effects on labor markets, according to a report published by the Robert Wood Johnson Foundation and the Urban Institute.
Report: How Have Workers Fared Under the ACA?
USPSTF Suggests Universal HIV Screening, PrEP for High-Risk Patients
TUESDAY, Nov. 20, 2018 (HealthDay News) — The U.S. Preventive Services Task Force (USPSTF) recommends HIV screening for individuals aged 15 to 65 years, including all pregnant women, and pre-exposure prophylaxis (PrEP) should be offered to those at high risk of HIV. These findings form the basis of two draft recommendation statements published online Nov. 20 by the USPSTF.
Draft Evidence Review – Adolescents/Adults
Draft Recommendation Statement – Adolescents/Adults
Comment on Recommendation Statement – Adolescents/Adults
Draft Evidence Review – Pregnancy
Draft Recommendation Statement – Pregnancy
Comment on Recommendation Statement – Pregnancy
Draft Evidence Review – PrEP
Draft Recommendation Statement – PrEP
Comment on Recommendation Statement – PrEP
HIV Transmission Risk Small With Antiretroviral Compliance
MONDAY, Nov. 19, 2018 (HealthDay News) — The risk for sexual transmission of HIV is negligible when an HIV-positive sex partner adheres to antiretroviral therapy and maintains viral suppression, according to research published in the November issue of CMAJ, the journal of the Canadian Medical Association.
CDC: 8.8 Percent Uninsured in U.S. in First Half of 2018
FDA Could Ease Blood Donation Rules for Gay Men 
Another Significant HIV Vaccine Trial Fails 
Women Experiencing Intimate Partner Violence More Likely to Contract HIV 
Cognitive Behavioral Intervention Ups ART Adherence in Adolescents, Young Adults 
Anifrolumab Tied to Lower Hospitalization, Infection Risk in Lupus 
Therapies Compared for Newly Diagnosed Multiple Sclerosis 
Trends Reported in Vaccination Coverage for Adolescents for 2025 
Initial Rx Length Tied to Long-Term Use of Z-Drugs 
.jpg)